Health-Related quality of life and DNA Methylation-Based aging biomarkers among survivors of childhood cancer.

Journal: Journal of the National Cancer Institute

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN, USA. College of Pharmacy, Chungbuk National University, Cheongju, Korea. Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN, USA. Hartwell Center, St Jude Children's Research Hospital, Memphis, TN, USA. State Key Laboratory of Oncogenes and Related Genes, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Department of Psychology, St Jude Children's Research Hospital, Memphis, TN, USA.

Abstract summary 

Childhood cancer survivors are at high risk for morbidity and mortality and poor patient-reported outcomes, typically health-related-quality-of-life (HRQOL). However, associations between DNA methylation (DNAm)-based aging biomarkers and HRQOL have not been evaluated.DNAm was generated with Infinium EPIC BeadChip on blood-derived DNA (median[range] for age at blood draw = 34.5[18.5-66.6] years) and HRQOL was assessed with age at survey (32.3[18.4-64.5] years) from 2,206 survivors in the St Jude Lifetime Cohort. DNAm-based aging biomarkers, including epigenetic age using multiple clocks (eg, GrimAge) and others (eg, DNAmB2M beta-2-microglobulin; DNAmADM: adrenomedullin), were derived from the DNAm Age Calculator (https://dnamage.genetics.ucla.edu). HRQOL was assessed using the Medical Outcomes Study 36-Item Short-Form Health Survey to capture eight domains, and physical and mental component summaries (PCS and MCS). General linear models evaluated associations between HRQOL and epigenetic age acceleration (EAA, eg, EAA_GrimAge) or other age-adjusted DNAm-based biomarkers (eg, ageadj_DNAmB2M) after adjusting for age at blood draw, sex, cancer treatments, and DNAm-based surrogate for smoking pack-years. All P values were 2-sided.Worse HRQOL was associated with greater EAA_GrimAge (PCS β[95%CI]=-0.18[-0.251,-0.11] years, P = 1.85 × 10-5; and four individual HRQOL domains), followed by ageadj_DNAmB2M (PCS: -0.08[-0.124,-0.037], P = .003; and three individual HRQOL domains), and ageadj_DNAmADM (PCS: -0.082[-0.125,-0.039], P = .002; and two HRQOL domains). EAA_Hannum (Hannum clock) was not associated with any HRQOL.Overall and domain-specific measures of HRQOL are associated with DNAm measures of biological aging. Future longitudinal studies should test biological aging as a potential mechanism underlying the association between poor HRQOL and increased risk of clinically assessed adverse health outcomes.

Authors & Co-authors:  Plonski Pan Chen Dong Zhang Song Shelton Easton Mulder Zhang Neale Walker Wang Webster Brinkman Krull Armstrong Ness Hudson Li Huang Wang

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  22
Identifiers
Doi : djae046
SSN : 1460-2105
Study Population
Male,Female
Mesh Terms
Other Terms
Study Design
Study Approach
Country of Study
Publication Country
United States